Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €72.44 EUR
Change Today +0.238 / 0.33%
Volume 7.3K
MOR On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 4:00 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at morphosys ag (MOR)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
There is no Company Insiders data available.

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Gerald Möller Ph.D. 53 RelationshipsMember of Supervisory BoardHBM Healthcare Investments AG72
Frank Morich M.D., Ph.D. 8 RelationshipsMember of Supervisory BoardTakeda Pharmaceuticals International, Inc62
Karin Eastham CPA 78 RelationshipsMember of Supervisory BoardMorphosys AG66
Marc Cluzel M.D., Ph.D. 20 RelationshipsMember of Supervisory BoardSanofi-Aventis U.S. LLC60
Wendy Johnson 10 RelationshipsMember of Supervisory BoardAmpliPhi Biosciences Corporation63
Klaus Kühn 5 RelationshipsMember of Supervisory BoardMorphosys AG63
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €72.44 EUR +0.238

MOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ablynx NV €13.44 EUR +0.205
Genmab A/S kr642.00 DKK +4.00
ImmunoGen Inc $17.90 USD +0.04
Seattle Genetics Inc $47.34 USD -0.16
XOMA Corp $0.81 USD -0.0247
View Industry Companies
 

Industry Analysis

MOR

Industry Average

Valuation MOR Industry Range
Price/Earnings 57.6x
Price/Sales 16.2x
Price/Book 4.9x
Price/Cash Flow 58.1x
TEV/Sales 13.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.